Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | AO. Siefker-Radtke, A Necchi, SH Park, J Garca-Donas, RA Huddart, EF Burgess, MT Fleming, A Rezazadeh, B Mellado, S Varlamov, M Joshi, I Duran, ST Tagawa, A OHagan, AN Avadhani, B Zhong, PD Porre, Y Loriot | ||||||||||||
Title | First results from the primary analysis population of the phase 2 study of erdafitinib (ERDA; JNJ-42756493) in patients (pts) with metastatic or unresectable urothelial carcinoma (mUC) and FGFR alterations (FGFRalt). | ||||||||||||
|
|||||||||||||
URL | https://meetinglibrary.asco.org/record/160559/abstract | ||||||||||||
Abstract Text | J Clin Oncol 36, 2018 (suppl; abstr 4503) |